IL2 and neoplasm: However, the therapeutic efficacy was modest, while a wide array of side effects ranging from flu-like symptoms to life-threatening conditions such as vascular leak syndrome was reported, and so significant efforts were devoted to targeted activation or delivery of IL-2 to the tumor or secondary lymphoid tissue (MacDonald et al., 2021).